The discovery that it may be possible to treat mesothelioma with a drug derived from an Asian spice has researchers at Case Comprehensive Cancer Center in Ohio savoring the taste of triumph. Their findings appear this week in the print edition of the journal Clinical Cancer Research. Joined by colleagues from the Georg-Speyer-Haus in Frankfurt,